Cytomegalovirus (CMV)-specific cytotoxic T lymphocyte therapy resolve CMV diseases and refractory CMV infections in paediatric recipients of allogeneic haematopoietic stem cell transplantation
Bone Marrow Transplant
.
2022 Feb;57(2):271-275.
doi: 10.1038/s41409-021-01499-0.
Epub 2021 Oct 20.
Authors
Xiaodong Wang
#
1
,
Uet Yu
#
1
,
Chunlan Yang
#
1
,
Chunjing Wang
1
,
Xiaoling Zhang
1
,
Yue Li
1
,
Changgang Li
1
,
Feiqiu Wen
1
,
Sixi Liu
2
Affiliations
1
Department of Hematology and Oncology, Shenzhen Children's Hospital, Shenzhen, China.
2
Department of Hematology and Oncology, Shenzhen Children's Hospital, Shenzhen, China. tiger647@126.com.
#
Contributed equally.
PMID:
34671119
PMCID:
PMC8821006
DOI:
10.1038/s41409-021-01499-0
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Child
Cytomegalovirus
Cytomegalovirus Infections* / etiology
Hematopoietic Stem Cell Transplantation*
Humans
T-Lymphocytes, Cytotoxic